Management
Stephen M. Coutts, Ph.D., President, Chief Executive Officer and Director
Dr. Coutts assumed the duties of President, Chief Executive Officer, and Board Director of Biocept in September 2008. He has 30 years of experience in the pharmaceutical and biotechnical industries. Dr. Coutts most recently was Director of Pharmaceutical Development at Cypress Bioscience, Inc. and a principal at Alembic Biotech Consultants. Previously, he was President and Chief Operating Officer at Triad Therapeutics, Inc. and spent 11 years as Executive Vice President for Research and Development at La Jolla Pharmaceutical. Prior to this, Dr. Coutts held scientific director positions at Purdue Pharma and Revlon Health Care Group. Dr. Coutts holds a B.S. in Chemistry from San Diego State University, a Ph.D. in Biochemistry from Harvard University, and an M.B.A. from New York University.
Philip D. Cotter, Ph.D., FACMG, Vice President and Director of Clinical Laboratories
Prior to joining Biocept, Dr. Cotter was Director of Advanced Molecular Diagnostics at U.S. Labs in Irvine, California from 2002 to 2004. Previously, he was Director of Cytogenetics and Molecular Genetics at the Children's Hospital and Research Center in Oakland, California from 1996 to 2002 and Director of Molecular Cytogenetics at the Mount Sinai School of Medicine in New York from 1994 to 1996. He has published extensively in cytogenetics, molecular genetics and prenatal diagnosis. Dr. Cotter holds a Ph.D. in Biomedical Sciences from the Department of Human Genetics at the Mount Sinai School of Medicine in New York. He is Board Certified by the American Board of Medical Genetics in both clinical cytogenetics and clinical molecular genetics. He is also a Fellow of the American College of Medical Genetics and a Clinical Associate Professor of Pediatrics at the University of California San Francisco.
Stephen Mikolajczyk, Sr. Director
of Research and Development
Mr. Mikolajczyk has more than 30 years in research with a wide variety of fundamental protein, biochemical and immunological technologies, including extensive experience with diagnostic immunoassay development. Previously he held the position of Senior Staff Research Scientist/Group Manager, Clinical Discovery at Beckman Coulter, Inc., San Diego. During this time he received the Yamanouchi Award at the American Urological Association for his discoveries of several new diagnostic isoforms of PSA for use in prostate cancer. Mr. Mikolajczyk has more than 50 publications on his research findings in the scientific literature, and holds multiple patents. Mr. Mikolajczyk holds a B.A. in Chemistry from the University of California, San Diego.
Farideh Z. Bischoff, Ph.D., Director, Translational Research
and Development
Prior to joining Biocept, Dr. Bischoff had been a
full-time faculty member in the Department of Obstetrics/Gynecology at
Baylor College of Medicine from 1994 to 2007. An expert in clinical and
molecular human cytogenetics, she has conducted research in
non-invasive prenatal genetic testing and more recently cancer
screening and surveillance. For more than 14 years, Dr. Bischoff has
been a key investigator in the multi-center NIH/NICHD funded study
focused on establishment of protocols and investigations into the
clinical utility of circulating rare fetal cells. Dr. Bischoff has
published over 100 peer-reviewed papers and book chapters.
She holds a Ph.D. in Cancer Biology from University of Texas Graduate
School for Biomedical Sciences in Houston, Texas, with postdoctoral
training at M.D. Anderson Cancer Center.
Mr. Burns has more than 30 years of manufacturing experience, including 22 years in medical device manufacturing. Prior to joining Biocept he was Vice President of Manufacturing Operations at Abiomed, Inc. Mr. Burns has held executive positions in manufacturing and operations at Haemonetics Corporation and Boston Scientific Corporation. He has also held manufacturing management positions at Polaroid and BASF. Mr. Burns has a B.S. in Industrial Engineering from Northeastern University.
Kathe Houghtaling, Vice
President of Human Resources
Ms. Houghtaling has extensive human resources experience with medical
device companies. Prior to joining Biocept, she was Director of Human
Resources with Boston Scientific Corporation. Previously, she served as
a corporate officer of Interventional Technologies, a medical device
maker, and was a member of the committee that conducted due diligence
in preparation of the company's acquisition by Boston Scientific.
Ms. Houghtaling has a B.A. from Northeastern State College, Tahlequah,
Oklahoma.
Todd G. Johnson, Vice President of Sales & Marketing
Todd G. Johnson assumed the role of Vice President of Sales & Marketing effective August 26th, 2010. Mr. Johnson recently served as Vice President of Sales at Insight Health, a national diagnostic imaging company, from 2008 to 2010. Since 1993, he has served in various senior sales and marketing leadership positions with companies that specialize in oncology to include LabCorp, Esoterix, Abbott Laboratories, and Ventana Medical Systems. Prior to his sales and marketing positions, he served worldwide as a military pilot and intelligence officer in the US Army. Mr. Johnson has a BS in Engineering from the United States Military Academy (West Point) and a MBA from Webster University.
